Steve Abbott is CEO of Oxygen Mobility Solutions. Steve has launched, managed and driven to exit a number of profitable companies focusing on various markets which include nano-materials sensors, insect behavior control, Big-Data analytical systems and web security. His M&A activity has included transactions with both public and private entities. His focus on early stage stakeholder value has put him in a position to become a thought leader in combining traditional analytical processes with entrepreneurial activities.
Right DoseTM , significantly improves supplemental oxygen delivery to patients based on their actual physiologic need, enabling greater physical activity and mobility leading to improved patient outcomes. A large clinical market exists, with over 30 Million patients on oxygen in the US, and new oxygen equipment sales of over 650,000 units per year. Independent testing of all currently available oxygen conservers for clinical use has revealed highly variable performance leading to poor patient oxygenation during exertion, thereby limiting a patient’s ability to exercise. We have de-risked both clinical and regulatory issues and are seeking $1.2M to complete a commercial product.